title: Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.
abstract: BACKGROUND
  Hydatidiform mole (HM), the most common type of gestational trophoblastic diseases, can be considered as placenta with abnormal chromosome composition with potential of malignant transformation. Few biologic markers can predict subsequent development of persistent gestational trophoblastic neoplasia (GTN) requiring chemotherapy.
  
  
  METHODS
  Suppression subtractive hybridization (SSH) combined with cDNA microarray was used to compare the differential expression pattern of HM that spontaneously regressed and that subsequently developed metastatic GTN. Tissue-specific chips were constructed from the subtracted cDNA libraries, followed by cDNA microarray analysis. Verification by quantitative RNA analysis by real-time polymerase chain reaction (PCR) and immunohistochemical analysis was performed in 23 genotyped complete HM.
  
  
  RESULTS
  Sixteen differentially expressed transcripts were identified. Quantitative RNA analysis confirmed down-regulation of ferritin light polypeptide (FTL) (P = 0.037) and insulin-like growth factor binding protein 1 (IGFBP1) (P = 0.037) in HM that subsequently developed GTN when compared with those HM that regressed. Immunohistochemical analysis further confirmed reduced IGFBP1 protein (P = 0.03) expression in HM that developed GTN.
  
  
  CONCLUSIONS
  Findings showed that reduced expression of genes related to cell invasion and immunosuppression, especially FTL and IGFBP1, were associated with development of GTN, and this finding may provide a better understanding of the pathogenesis of GTN. The potential application of FTL and IGFBP1 in management of patients with HM should be explored.
authors.affiliation: Department of Anatomy, The University of Hong Kong, Pokfulam, Queen Mary Hospital, Hong Kong, China.
authors.forename: Hui-Chen
authors.initials: HC
authors.lastname: Feng
authors.forename: Sai-Wah
authors.initials: SW
authors.lastname: Tsao
authors.forename: Hextan Y S
authors.initials: HY
authors.lastname: Ngan
authors.forename: Wei-Cheng
authors.initials: WC
authors.lastname: Xue
authors.forename: Pui-Man
authors.initials: PM
authors.lastname: Chiu
authors.forename: Annie N Y
authors.initials: AN
authors.lastname: Cheung
mesh_terms: D000293:Adolescent; D000328:Adult; D001052:Apoferritins; D018076:DNA, Complementary / Q000235:genetics; D005260:Female; D005293:Ferritins; D006801:Humans; D017403:In Situ Hybridization / Q000379:methods; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000235:genetics*; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D010455:Peptides / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000235:genetics*; D014328:Trophoblastic Neoplasms / Q000235:genetics*; D014594:Uterine Neoplasms / Q000235:genetics*
chemical_list: D018076:DNA, Complementary; C507433:FTL protein, human; D018970:Insulin-Like Growth Factor Binding Protein 1; D010455:Peptides; D005293:Ferritins; D001052:Apoferritins